Skip to main content

Medically Prescribed Health apps Market Rising Share, Global Trends, Technological Need Insights on Rising Trends

Health apps are software applications designed to provide health services over mobile devices. They assist patients by managing their medical condition in real-time and gaining advice from medical professionals via the mobile phone. The global Health apps market report is an ubiquitousness of smartphones and smart devices have ensured the development of mobile applications.
Some of the Top Market Growth Drivers in the Medically Prescribed Health apps Market in 2020 are –
BioTelemetry Inc., iHealth Lab, Inc., Apple, Inc. Sanofi, AirStrip Technologies, LifeWatch AG, and Others.
These health apps assist patients to manage their medical condition on the real-time basis and provide the feedback back to professionals. The normal human functions such as blood pressure, blood sugar, heart rate, calories burned, cholesterol, and other fitness related data are displayed on a dashboard of the app with the help of the health-based app. According to the National Center for Biotechnology Information (NCBI), 68% of patients in the U.S. use a mobile health (mHealth) application for gaining advice on health problems and booking appointments.
Rise in healthcare facilities and medical professionals jumping on board the digital application bandwagon can bode well for the market. Presence of advanced telecommunication networks and a plethora of platforms for professionals to offer their expertise to patients can bolster the global Health apps market demand in the coming years.
Lack of patient awareness and hazy policies concerning patient information can pose a challenge to the market growth.
Industry News
Tandem Diabetes Care recently got approval for its Control-IQ Technology by the U.S. FDA to be used in insulin pumps. The algorithm allows automated insulin delivery while connected to an insulin pump and continuous glucose monitor. The approval was sanctioned due to the controller’s ability to deliver precise doses to type 1 diabetes patients without any external help.
Global Prescribed Health apps Market Segmentation
The Prescribed Health apps market is segmented by type, device, application, and end-user.
By type:                             Windows, Android, Iphone, And Others.
By device:                         Multi-Parameter Tracker, Cardiac Monitoring Device, Diabetes Management Device, And Others.
By application:                Lifestyle Management, Disease Management, Fitness, Nutrition, And Diet, Medication Adherence, And Others.
By end-user:                    Home Care, Specialty Centers, Hospitals, Sand Others.
TABLE OF CONTENTS:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
Chapter 3. Research Methodology
Chapter 4. Market Dynamics
Chapter 5. Market Factor Analysis
Chapter 6. Global Prescribed Health Apps Market, By Product
Chapter 7. Global Prescribed Health Apps Market, By Application
Chapter 8. Global Prescribed Health Apps Market, By Region
Chapter 9. Company Landscape
Chapter 10. Company Profiles
Chapter 11 MRFR Conclusion
Chapter 12. Appendix
  • LIST OF TABLES
  • LIST OF FIGURES
Regional Analysis
Asia Pacific (APAC), the Americas, the Middle East & Africa (MEA), and Europe are regions covered in the global Health apps market report 2020.
The Americas is expected to garner significant revenue by 2023 due to the utilization of chronic disease management by physicians on health-based applications. According to a recent survey, nearly 35% parents and 17% teens use a health application Increasing demand for health apps and the high penetration rate of smartphones in healthcare settings are other drivers of the regional market.
Europe is the second largest region for the global Health apps market after the Americas. Awareness of chronic disease management and development of medical applications can drive the regional market growth. Rising investment in health applications specially in the U.K. and Germany can augment the global market size by a considerable mark.
The APAC region can depict a robust growth rate during the forecast period due to prevalence of chronic diseases. Presence of developed economies of India and China combined with the large youth populace accustomed to mobile applications can drive the market growth.
About Market Research Future: Our team have supreme objective to provide the optimum quality market research and intelligence services to our clients. market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
+1 646 845 9312
Labels:

Comments

Post a Comment

Popular posts from this blog

Hemifacial Spasm Market Application Scope, Types, Technology Benefits and Global Business

  Hemifacial Spasm Market  Research Information: By Diagnosis (Mri, Ct Or Cat Scan, Angiography (Arteriography)), Treatment (Medical Treatment, Surgical Treatment, Combinational Therapy, Tens, Physical Therapy, Others), End User – Global Forecast Till 2023 Market Highlights: Hemifacial spasm is a condition that causes frequent muscle spasms, on one side of the face. The condition can affect both men and women, but it is most prevalent in middle-aged or older women. Its incidence rate is also found to be higher among the Asian population. A number of factors such as increasing technological advancements, rising public awareness, increased incidence of craniofacial tremor, and facial chorea, unmet medical needs, increasing government assistance, improving regulatory framework, increasing adoption rate, and improvement in funding and reimbursement policies are propelling the growth of the global hemifacial spasm market. However, difficult diagnosis, cost of treatment, side-effect...
Post a Comment
Read more

U.S. Uterine Fibroid Market Latest Devices, Key Players Statistics Data, Regional Business Outlook 2022

U.S. Uterine Fibroid Market by Type (Subserosal Fibroids, Intramural Fibroids, Submucosal Fibroids and others), by Diagnosis (Medical Resonance Imaging (MRI) scanners, Computed Tomography (CT), Ultrasounds and others) and Treatment (Uterine Fibroid Embolization, Magnetic Resonance Guided Focused Ultrasound, Myolysis, Endometrial Ablation, Hysterectomy and Myomectomy) - Forecast to 2022 The  US Uterine Fibroid Market  report offers insights into the leading market players and presents an assessment of their current market position. Company information with regards to revenue, segmental share, geographical income, SWOT, growth strategies, new product launch, M&A activities, and the latest R&D initiatives is also available in the report Major Key Players To gain a substantially large competitive advantage, these players incorporate strategic initiatives such as mergers & acquisitions, collaboration, expansion, and product launch. These are the Top Market...
Post a Comment
Read more

Global Merkel Cell Carcinoma Market Clincial Assessment and Professional Industry Outlook 2023

  Global Merkel Cell Carcinoma Market  Research Report: By Diagnosis (Physical Examination, Sentinel Node Biopsy, Imaging Test), Treatment (Surgery, Radiation Therapy, Chemotherapy), End User (Hospitals & Clinics, Diagnostic Centers) – Forecast till 2023 Market Highlights Increasing prevalence of Merkel cell carcinoma and growing geriatric population are estimated to be the major drivers for the market growth during the forecast period. Moreover, increasing R&D expenses by the key market players, rising mortality rate by MCC, and growing healthcare expenditure is further boosting the market growth. However, the high cost of therapeutics and related side effects along with the lack of awareness and low per capita healthcare expenditures in the developing economies restrains the market growth.  Intended Audience Pharmaceutical Companies Biotechnological Institutes Government and Private Laboratories Research and Development (R&D) Companies Medical Research Labor...
Post a Comment
Read more